Patents
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
02/2004
02/04/2004CN1137121C Process for preparation of 2-aminothiazolecarboxamide derivatives
02/03/2004US6686476 Substituted 1-aryl-3-heteroaryl-thioureas and substituted 1-aryl-3-heteroaryl-isothioureas as antiatherosclerotic agents
02/03/2004US6686475 Compounds
02/03/2004US6686381 Compounds that antagonize neuropeptide y at the y5 receptor subtype represent an approach to the treatment of eating disorders such as obesity and hyperphagia
02/03/2004US6686368 Inhibitors of factor Xa
02/03/2004US6686350 Cell adhesion inhibitors
02/03/2004US6686345 DNA-cleaving antitumor agents
02/03/2004US6685617 4-(((-1-carboxy-2-(4-((2,6-dichlorobenzoyl)amine)phenyl)ethyl) amino)carbonyl)-3-oxo-3-thiazolidinebutanoic acid, used as antagonists for cellular adhesion molecules, and administered as antiinflammatory agents
01/2004
01/29/2004WO2004009565A2 Acylaminothiazole derivatives, preparation and therapeutic use thereof
01/29/2004WO2004009552A1 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs
01/29/2004WO2004009017A2 Modulators of the glucocorticoid receptor and method
01/29/2004WO2003066035A3 Compounds for inhibiting insulin secretion and methods related thereto
01/29/2004WO2003059864A3 Pheny(alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity
01/29/2004WO2003053971A8 Pyridoquinoxaline antivirals
01/29/2004WO2003049705A3 Use of pramipexole to treat amyotrophic lateral sclerosis
01/29/2004WO2003035613A3 Nitrogen heterocycle inhibitors of aspartyl protease
01/29/2004WO2003000180A3 Dipeptidyl peptidase inhibitors for the treatment of diabetes
01/29/2004US20040019219 N-alkylated thiazolium salts and process for their preparation
01/29/2004US20040019218 Reacting nitrogen compounds such as benzoxazole, with grignard reagents to form chemical intermediates used to form cysteine protease inhibitors
01/29/2004US20040019090 2-(4-(2-(2-biphenyl-yl-5-methyl-thiazol-4-yl)-alkoxy)-phenoxy) -2-methyl-propionic acid derivatives; antidiabetic agents
01/29/2004US20040019089 Multidrug resistant cell inhibitors; anticancer agents
01/29/2004US20040019086 Aminediols for the treatment of Alzheimer's disease
01/29/2004US20040019050 Selective NPY (Y5) antagonists (triazines)
01/29/2004US20040019039 Substituted piperazines and diazepanes
01/29/2004US20040016063 1,3-Dihydroxybenzene derivatives and colorants containing said compounds
01/29/2004CA2492907A1 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs
01/28/2004EP1383760A1 Biarylcarboxamide compounds as apolipoprotein b inhibitors
01/28/2004EP1383751A1 Novel azoles having an insecticidal action
01/28/2004EP1383748A2 Novel compounds and compositions as cathepsin inhibitors
01/28/2004EP1383731A1 Biaryl compounds as serine protease inhibitors
01/28/2004EP1383729A1 Peptide deformylase inhibitors
01/28/2004EP1183237B1 Novel antioxidants, preparation methods and uses
01/28/2004CN1471518A Process for the manufacture of thiazole derivativs with pesticide activity
01/28/2004CN1471393A Method for the treatment of neurological and neuropsychological disorders
01/28/2004CN1471392A Method for the treatment of neurological and neuropsychological disorders
01/28/2004CN1136204C Process for preparing 2-imidazoline-5-one fungicide
01/28/2004CN1136193C Imide derivatives ar Salts thereof
01/27/2004US6683215 N-(4-carbamimidoyl-phenyl)-glycine derivatives
01/27/2004US6683211 Fungicides for crops
01/27/2004US6683191 Preparing a azole compound on a solid support resin, cleaving the compound from the solid support resin by nucleophilic substitution to further substituting by alkylation reaction
01/27/2004US6683099 Substituted N,N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
01/27/2004US6682782 Organic compound having an acetylene group, vacuum deposition polymerization thereof, deposited polymerized thin film, and electroluminescence device containing same
01/22/2004WO2004007492A1 Novel macrocycles for the treatment of cancer
01/22/2004WO2004007491A1 Azolidinone-vinyl fused-benzene derivatives
01/22/2004WO2004007483A1 Novel macrocycles for the treatment of cancer diseases
01/22/2004WO2004007476A1 Gesellschaft für biotechnologische forschung mbh (gbf)
01/22/2004WO2004007447A1 Squarylium compound, metal complex thereof, and organic el element containing these
01/22/2004WO2004007427A1 N-methyl amino acids
01/22/2004WO2004006878A1 Merocyanine derivatives for cosmetic use
01/22/2004WO2003080545A3 Substituted phenylacetic acids
01/22/2004WO2003024395A8 Linked biaryl compounds
01/22/2004WO2003024390A3 Hydroxyeicosenoic acid analogs
01/22/2004WO2002074268A3 Dyeing compositions for the dyeing of keratin fibres, comprising heterocyclic hydrazone compounds
01/22/2004US20040014968 Such as 2-(3-chloro-phenyl)-3-cyclopentyl-N-thiazol-2-yl-propionamide which increases insulin secretion in treatment of type II diabetes
01/22/2004US20040014903 Adhesion promoting compounds or resins containing a thiazole functionality (including benzothiazole) and a polymerizable functionality (Z) give improved adhesive strength to metal substrates. A representative structure is the following, in
01/22/2004US20040014784 Substituted propargylamines
01/22/2004US20040014774 Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
01/22/2004US20040014758 Benzylcycloalkyl amines as modulators of chemokine receptor activity
01/22/2004US20040011639 Method for purifying 2-chloro-5-chloromethyl thiazole
01/22/2004DE10230872A1 Verfahren zur Herstellung von substituierten Thiazol-2-ylmethylestern A process for the preparation of substituted thiazol-2-ylmethylestern
01/22/2004DE10229776A1 Verfahren zum Herstellen von heterocyclischen Fluoralkenylsulfonen A method for producing heterocyclic Fluoralkenylsulfonen
01/22/2004CA2491422A1 Novel macrocycles for the treatment of cancer diseases
01/21/2004EP1382600A1 Curable compositions containing thiazole functionality
01/21/2004EP1382333A2 Use of beta 3 adrenergic receptor agonists in the treatment of dysuria
01/21/2004EP1381596A1 Thiazolyl-substituted carbocyclic 1,3-diones as pesticidal agents
01/21/2004EP1381590A1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
01/21/2004EP1257265B1 Use of 2-phenylene diamine derivatives for the treatment of infections
01/21/2004EP0948491B1 Aminothiazole derivatives useful in the preparation of beta-lactam antibiotics
01/21/2004CN1469876A Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists
01/21/2004CN1469870A A process for the preparation of bis-benzazolyl compounds
01/21/2004CN1469862A 2,2-diphenyl butanamide derivatives and medicines containing the same
01/21/2004CN1468855A Heterocyclic carboxylic ester reducing process
01/20/2004US6680387 Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
01/20/2004US6680325 Agents for combating plant pests
01/20/2004US6680125 Coating composition and method for preparing the same, and scuff-resistant plastic lense
01/20/2004CA2284795C Novel pyrimidine derivatives and processes for the preparation thereof
01/20/2004CA2089441C Process for the preparation of cephem prodrug esters
01/15/2004WO2004005513A2 Methods for specifically inhibiting histone deacetylase-7 and 8
01/15/2004WO2004005278A1 Bisarylsulfonamide compounds and their use in cancer therapy
01/15/2004WO2004005269A1 Method for producing substituted thiazol-2-yl methyl esters
01/15/2004WO2004005268A1 Method for producing heterocyclic fluoroalkenyl sulfones
01/15/2004WO2004005267A2 Heteroaryl compounds useful in treating inflammatory disorders
01/15/2004WO2004005229A1 Modulators of the glucocorticoid receptor
01/15/2004WO2002055025A3 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (bvdv) infection and hepatitis c virus (hcv) infection
01/15/2004US20040010150 Process for making 2-amino-5-cyanothiazole compounds
01/15/2004US20040009979 Use of compounds for the elevation of pyruvate dehydrogenase activity
01/15/2004US20040009877 Hetaryl-substituted heterocycles
01/15/2004US20040009527 4-(2-imino-4-oxo-thiazolidin-5-ylidenemethyl)-benzoic acid, having at least two binding sites, selectivity binding to a receptor protein or oxidoreductase enzyme; drug design
01/15/2004CA2491994A1 Modulators of the glucocorticoid receptor
01/15/2004CA2490579A1 Methods for specifically inhibiting histone deacetylase-7 and 8
01/15/2004CA2488816A1 Bisarylsulfonamide compounds and their use in cancer therapy
01/14/2004EP1380577A1 Thiazoline acid derivatives
01/14/2004EP1380564A1 Binaphtol derivative and process for producing the same
01/14/2004EP1380562A1 Carboxylic acid derivative and salt thereof
01/14/2004EP1379514A2 5-membered heterocycles, preparation and application thereof as medicaments
01/14/2004EP1379510A1 Aryl and heteroaryl urea chk1 inhibitors for use as radiosensitizers and chamosensitizers
01/14/2004EP1379508A2 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
01/14/2004EP1379498A1 Sulphones which modulate the action of gamma secretase
01/14/2004EP1379243A1 Methods for treating metabolic diseases using malonyl-coa decarboxylase inhibitors
01/14/2004EP1379239A2 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor